AKUMS Stock Overview
Manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for AKUMS from our risk checks.
Akums Drugs and Pharmaceuticals Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹580.65 |
| 52 Week High | ₹1,175.90 |
| 52 Week Low | ₹530.05 |
| Beta | 0 |
| 11 Month Change | -36.59% |
| 3 Month Change | -39.53% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -27.08% |
Recent News & Updates
Recent updates
Shareholder Returns
| AKUMS | IN Life Sciences | IN Market | |
|---|---|---|---|
| 7D | -5.2% | -0.3% | -1.8% |
| 1Y | n/a | 47.9% | 27.2% |
Return vs Industry: Insufficient data to determine how AKUMS performed against the Indian Life Sciences industry.
Return vs Market: Insufficient data to determine how AKUMS performed against the Indian Market.
Price Volatility
| AKUMS volatility | |
|---|---|
| AKUMS Average Weekly Movement | 7.1% |
| Life Sciences Industry Average Movement | 6.5% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in IN Market | 9.2% |
| 10% least volatile stocks in IN Market | 4.0% |
Stable Share Price: AKUMS has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: Insufficient data to determine AKUMS's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 7,388 | Sanjeev Jain | www.akums.in |
Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. It offers dosage forms, such as tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form fill seals, topical preparations, eye drops, dry powder injections, rotacaps and gummies, and others. The company operates as pharmaceutical contract development and manufacturing company.
Akums Drugs and Pharmaceuticals Limited Fundamentals Summary
| AKUMS fundamental statistics | |
|---|---|
| Market cap | ₹91.39b |
| Earnings (TTM) | ₹2.78b |
| Revenue (TTM) | ₹40.83b |
32.9x
P/E Ratio2.2x
P/S RatioIs AKUMS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AKUMS income statement (TTM) | |
|---|---|
| Revenue | ₹40.83b |
| Cost of Revenue | ₹25.17b |
| Gross Profit | ₹15.66b |
| Other Expenses | ₹12.88b |
| Earnings | ₹2.78b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 17.65 |
| Gross Margin | 38.35% |
| Net Profit Margin | 6.80% |
| Debt/Equity Ratio | 16.1% |
How did AKUMS perform over the long term?
See historical performance and comparison